228 related articles for article (PubMed ID: 27015121)
1. Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Shen JX; Liu J; Li GW; Huang YT; Wu HT
Oncotarget; 2016 May; 7(18):25340-9. PubMed ID: 27015121
[TBL] [Abstract][Full Text] [Related]
2. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
3. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
[TBL] [Abstract][Full Text] [Related]
4. The prognostic roles of ALDH1 isoenzymes in gastric cancer.
Li K; Guo X; Wang Z; Li X; Bu Y; Bai X; Zheng L; Huang Y
Onco Targets Ther; 2016; 9():3405-14. PubMed ID: 27354812
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
Ma YM; Zhao S
Onco Targets Ther; 2016; 9():1981-8. PubMed ID: 27110126
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Yang CK; Wang XK; Liao XW; Han CY; Yu TD; Qin W; Zhu GZ; Su H; Yu L; Liu XG; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
PLoS One; 2017; 12(8):e0182208. PubMed ID: 28792511
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
8. Mining topoisomerase isoforms in gastric cancer.
Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
[TBL] [Abstract][Full Text] [Related]
10. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.
Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y
Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797
[TBL] [Abstract][Full Text] [Related]
11. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
16. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K
J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847
[TBL] [Abstract][Full Text] [Related]
17. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
[TBL] [Abstract][Full Text] [Related]
18. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
[TBL] [Abstract][Full Text] [Related]
19. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Ruscito I; Darb-Esfahani S; Kulbe H; Bellati F; Zizzari IG; Rahimi Koshkaki H; Napoletano C; Caserta D; Rughetti A; Kessler M; Sehouli J; Nuti M; Braicu EI
Gynecol Oncol; 2018 Jul; 150(1):151-157. PubMed ID: 29753392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
